Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of relevance. This is page number 17.
Order by Relevance | Date
Total 2010 results found since Jan 2013.
Risk of Guillain-Barre syndrome following herpes zoster, United States, 2010-2018
This study provides new and methodologically rigorous epidemiologic support for an association between HZ and GBS, and useful context regarding the benefits versus potential risks of zoster vaccination.PMID:34856864 | DOI:10.1080/21645515.2021.1985890
Source: Herpes - December 3, 2021 Category: Infectious Diseases Authors: Tara C Anderson Jessica W Leung Rafael Harpaz Kathleen L Dooling Source Type: research
Comparison of rates of dementia among older adult recipients of two, one, or no vaccinations
CONCLUSIONS AND RELEVANCE: Receiving two types of vaccinations versus one type was associated with lower dementia risk. Vaccinations may have non-specific associations with incident dementia. Low cost and accessible, common adult vaccinations may be an overlooked intervention for reducing dementia risk.PMID:34897645 | DOI:10.1111/jgs.17606
Source: Herpes - December 13, 2021 Category: Infectious Diseases Authors: Timothy L Wiemken Joanne Salas John E Morley Daniel F Hoft Christine Jacobs Jeffrey F Scherrer Source Type: research
Impact of a structured older persons health assessment on herpes zoster vaccine uptake in Australian primary care
In conclusion, the structured older persons health assessment, which acts as both an incentive and a reminder for healthcare providers to recommend vaccinations in adults improves uptake of zoster vaccine in eligible adults. Such interventions may have a role in improving vaccine uptake among older adults.PMID:34973282 | DOI:10.1016/j.ypmed.2021.106946
Source: Herpes - January 1, 2022 Category: Infectious Diseases Authors: Jialing Lin Timothy Dobbins James G Wood John J Hall Bette Liu Source Type: research
A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine
Am J Epidemiol. 2022 Feb 12:kwac030. doi: 10.1093/aje/kwac030. Online ahead of print.ABSTRACTThe recombinant herpes zoster vaccine (RZV), approved as a 2-dose series in the U.S. in October 2017, has proven highly effective and generally safe. However, a small risk of Guillain-Barré syndrome (GBS) after vaccination was identified post-approval, and questions remain about other possible adverse events. This data-mining study assessed RZV safety in the U.S. using the self-controlled tree-temporal scan statistic, scanning data on thousands of diagnoses recorded during follow-up to detect any statistically unusual temporal clu...
Source: Herpes - February 13, 2022 Category: Infectious Diseases Authors: W Katherine Yih Martin Kulldorff Inna Dashevsky Judith C Maro Source Type: research
Burden of opioid use for pain management among adult herpes zoster patients in the US and the potential impact of vaccination
Hum Vaccin Immunother. 2022 Apr 1:1-11. doi: 10.1080/21645515.2022.2040328. Online ahead of print.ABSTRACTPLAIN LANGUAGE SUMMARYWhat is the context? Herpes zoster or shingles and its complications such as postherpetic neuralgia - a painful condition that affects the nerve fibers and skin - may lead to complex pain that can be addressed using opioids in some patients.The recombinant zoster vaccine (RZV) vaccine prevents shingles and, therefore, may reduce the use of opioids and the negative health outcomes and costs associated with it.What is new? In this retrospective medical claims study, including patients between 2012 a...
Source: Herpes - April 1, 2022 Category: Infectious Diseases Authors: Jean-Etienne Poirrier Jessica K DeMartino Saurabh Nagar Justin Carrico Katherine Hicks Juliana Meyers Jeffrey Stoddard Source Type: research
Herpes Zoster in the era of COVID 19: A prospective observational study to probe the association of herpes zoster with COVID 19 infection and vaccination
CONCLUSIONS: Experts must be aware of the probable increased risk of HZ during the Covid 19 pandemic. We propose appropriate curative and preventive measures against herpes zoster infection, including a systematic follow-up of these patients to ensure that they stick to extreme safety measures till the diagnosis of COVID-19 is omitted This article is protected by copyright. All rights reserved.PMID:35434963 | DOI:10.1111/dth.15521
Source: Herpes - April 18, 2022 Category: Infectious Diseases Authors: Nawaf Almutairi Abdulrahman N Almutairi Moneerah Almazyad Sabika Alwazzan Source Type: research
Capturing the value of vaccination: impact of vaccine-preventable disease on hospitalization
Aging Clin Exp Res. 2022 May 28. doi: 10.1007/s40520-022-02110-2. Online ahead of print.ABSTRACTEvidence from epidemiological studies suggests that vaccine-preventable disease (VPD) such as influenza or herpes zoster contribute significantly to the increased risk of older adults for cardiovascular, cerebrovascular, neurological, and renal complications in the period after illnesses. However, since the period of elevated risk can persist well beyond the duration of the acute illness, the connection is not always recognized. To obtain insights into the relationship between diagnoses for vaccine-preventable disease and for ot...
Source: Aging Clinical and Experimental Research - May 28, 2022 Category: Geriatrics Authors: Mark T Doherty Emmanuel Aris Nathalie Servotte Ekkehard Beck Source Type: research
